USNA — USANA Health Sciences Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesBalancedMid CapSuper Stock

Annual income statement for USANA Health Sciences, fiscal year end - December 28th, USD millions except per share, conversion factor applied.

	2021 January 2nd	2022 December 31st	2022 January 1st	2023 December 30th	2024 December 28th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,135	999	1,186	921	855
Cost of Revenue
Gross Profit	926	805	969	744	693
Selling / General / Administrative Expenses
Research And Development
Total Operating Expenses	958	891	1,016	828	788
Operating Profit	176	108	170	93.1	66.3
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	178	109	171	102	76.4
Provision for Income Taxes
Net Income After Taxes	125	69.3	117	63.8	42.1
Minority Interest
Net Income Before Extraordinary Items
Net Income	125	69.3	117	63.8	42
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	125	69.3	117	63.8	42
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	5.86	3.59	5.73	3.3	2.19